These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11906747)

  • 21. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J; Enzing C; Joly PB; Reiss T
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract]   [Full Text] [Related]  

  • 22. Academic industry relationships in biotechnology: a primer on policy and practice.
    Campbell EG; Blumenthal D
    Cloning; 2000; 2(3):129-36. PubMed ID: 16218849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biotechnology in the modern world: benefits and risks].
    Blium IaB
    Tsitol Genet; 2002; 36(1):59-79. PubMed ID: 12012599
    [No Abstract]   [Full Text] [Related]  

  • 24. Perspective: A tale of 'cautious pessimism': Biotechnology, recession and the 'new economy'.
    Kewell B; Webster A
    Biotechnol J; 2009 Aug; 4(8):1106-8. PubMed ID: 19685467
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategic rethink for German biotechnology.
    Fernandes M; Miska D
    Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106
    [No Abstract]   [Full Text] [Related]  

  • 26. Vox populi and public policy: why should we care?
    Miller HI
    Nat Biotechnol; 2003 Dec; 21(12):1431-2. PubMed ID: 14647319
    [No Abstract]   [Full Text] [Related]  

  • 27. Nuclear power risks: challenge to the credibility of science.
    Welch BL
    Int J Health Serv; 1980; 10(1):5-36. PubMed ID: 7353936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotechnology: delivering on the promise.
    Greenwood JC
    Sci Transl Med; 2010 Jan; 2(13):13cm1. PubMed ID: 20371460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
    Rose SL; Highland J; Karafa MT; Joffe S
    JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First U.S.-Russian business venture in closed nuclear city.
    Lopatto J; Wilkes B
    Health Phys; 2004 Feb; 86(2):212-3. PubMed ID: 14744060
    [No Abstract]   [Full Text] [Related]  

  • 32. How should public policy respond to the challenges of modern biotechnology?
    Cantley M
    Curr Opin Biotechnol; 2004 Jun; 15(3):258-63. PubMed ID: 15193337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. People's concerns about biotechnology: some problems and some solutions.
    Braun R
    J Biotechnol; 2002 Sep; 98(1):3-8. PubMed ID: 12126801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape.
    Mackey TK; Annaloro J
    Drug Discov Today; 2018 Jul; 23(7):1324-1327. PubMed ID: 29501912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human dignity: a guide to policy making in the biotechnology era?
    Caulfield T; Brownsword R
    Nat Rev Genet; 2006 Jan; 7(1):72-6. PubMed ID: 16344853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotechs opt for alternative floatation strategy.
    Ratner M
    Nat Biotechnol; 2012 Sep; 30(9):814. PubMed ID: 22965036
    [No Abstract]   [Full Text] [Related]  

  • 37. Worlds apart? The reception of genetically modified foods in Europe and the U.S.
    Gaskell G; Bauer MW; Durant J; Allum NC
    Science; 1999 Jul; 285(5426):384-7. PubMed ID: 10411496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agbiotech issues climb US political agenda.
    Fox JL
    Nat Biotechnol; 2002 Dec; 20(12):1179-80. PubMed ID: 12454658
    [No Abstract]   [Full Text] [Related]  

  • 39. The policy outlook from the Hill.
    Vastag B
    Nat Biotechnol; 2007 Jan; 25(1):13-6. PubMed ID: 17211381
    [No Abstract]   [Full Text] [Related]  

  • 40. Agbiotech climbs Africa's agenda.
    Fox JL
    Nat Biotechnol; 2003 Jun; 21(6):589. PubMed ID: 12776132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.